Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome

Figure 6 Change in the number of patients in different irritable bowel syndrome severity scoring system severity categories from baseline to after treatment with B. longum 35624. A: Number and percentage of patients by Irritable bowel syndrome severity scoring system (IBS-SSS) severity category at baseline (arrows indicate movement from one category to another one after 30 d of treatment with B. longum 35624); B: Number and percentage of patients by IBS-SSS severity category after 30 d of treatment with B. longum 35624. IBS-SSS: Irritable bowel syndrome severity scoring system.